CD9 and neoplasm: Similarly, trogocytosis of CD9 molecules from ovarian carcinoma cells to NK cells renders them less cytotoxic and poorer producers of anti-tumor cytokines, consistent with the identification of a CD9-positive NK cell subset in tubo-ovarian carcinoma samples which presence correlates with tumor progression (55).